How I self-advocate for researchers with disabilities and illnesses
Isobel Williams has an autoimmune disease. The support network that she co-founded is helping to improve life in academia for people with long-term health conditions.
News
Scientists rise up against statistical significance
Call for an end to hyped claims and the dismissal of possibly crucial effects.
Plagiarism detectors are a crutch, and a problem
Academics and editors need to stop pretending that software always catches recycled text and start reading more carefully.
Gender balance in research is improving, but pace is too slow: EU She Figures
The number of women with a career in research is slowly growing in Europe. Still, they remain significantly underrepresented, and their potential not fully recognised and valued.
What I wish my friends and family knew about my PhD
Support must come from a place of understanding.
Top US institutes still aren’t reporting clinical-trial results on time
US law requires researchers to post study findings on a public registry within a year of completion — or face heavy fines.
New Horizon Impact Award 2019 contest opens: apply by 28 May
The prize acknowledges and rewards the most influential and impactful project results under Horizon 2020, the EU research and innovation programme, and its predecessor, the 7th Framework programme.
Algorithm for a “deep learning” process can predict OCT measurements from colour fundus photographs
Research scientists in Switzerland and the United States have published a new study to apply “deep learning” (DL) algorithms using colour fundus photographs (CFPs) to detect 97% accuracy results in diabetic macular edema (DME).
Nightstar Therapeutics plc acquires Biogen estimated at $877M
Nightstar Therapeutics plc,. (NASDAQ: NITE), has reported that an acquisition agreement with Biogen will buy at a price of $25.50 per share and to be completed in mid-year 2019.
Working Scientist podcast: How to beat research funding's boom and bust cycle
How governments decide when to boost basic research funding, and when to scale back support.
Applying AI in fundus images
The approval last year for the first autonomous artificial intelligence (AI) to make a diagnosis without a physician has opened new doors for the first medical device to use AI to diagnose moderate or worse diabetic retinopathy or macular edema in adults who have diabetes.
We need to talk about systematic fraud
Software that uncovers suspicious papers will do little for a community that does not confront organized research fraud.
Working Scientist podcast: The grant funding lottery and how to fix it
Many grant funding decisions are random, with luck playing a large part. How can the system be improved, particularly when funds are tight?
Overdue: a US advisory board for research integrity
When it comes to fostering rigour and scientific integrity, US research institutions are stuck.